Transparency International (TI) is the world’s leading non-governmental anticorruption organisation, addressing corruption in its many forms through a network of more than 100 national chapters worldwide. The World Health Organization Collaborating Centre (WHO CC) for Governance, Accountability, and Transparency in the Pharmaceutical Sector was established in 2015 at the Leslie Dan Faculty of Pharmacy, University of Toronto.
Some of the observations are:
6 or 30% are being made by developers based in countries that do not align to best practice and require the reporting of clinical trial summary results within 12 months of trial completion.
Clinical study reports are only made available in two of the nine countries
There were no publicly accessible protocols for 88% of the registered trials in our analysis, meaning that we are missing key details of how the clinical trials have been ran.
At least some clinical trial results have been announced for 18 of the 20 vaccines in our analysis. Two vaccines developed by AnGes and Zydus Cadila have announced no trial results
Results have been announced for 45% of the total registered clinical trials in our analysis
Of these 41 per cent have no published data analysis, meaning that only top-level results were provided through a press release, press conference or media report, with minimal data
A total of 182 agreements for the purchase of 12 different COVID-19 vaccines Just 6% of vaccine contracts between developers and public buyers have been published through formal channels.
For AstraZeneca’s vaccine, upper-middle income countries like South Africa are paying an average of 25% more per contract than high income countries like the USA.
